BLUME THORSTEN
No ORCID on file
· 36 papers in corpus
· active 2010-2011
Frequent coauthors
- KUHNKE JOACHIM 36
- OTTO CHRISTIANE 36
- SCHMEES NORBERT 36
- HELDMANN DIETER 24
- WINTERMANTEL TIM 24
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…